Stock OXYGEN BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Oxygen Biotherapeutics, Inc. Nasdaq

Equities

US69207P2092

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Oxygen Biotherapeutics, Inc.
May. 14 Tenax Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 28 Tenax Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Roth MKM Initiates Coverage on Tenax Therapeutics With Buy Rating, $6 Price Target
MT
Traders Digest Jobless Claims Data After Fed Rate Hike, Prompting Mixed Premarket Trading for US Equity Futures
MT
TENAX THERAPEUTICS : HC Wainwright Starts Tenax Therapeutics at Buy With $5 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TENX Stock
  4. Stock
  5. News Oxygen Biotherapeutics, Inc.
  6. Analyst Reco.